Picture of Surrozen logo

SRZN Surrozen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Surrozen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-32.7-54.6-36-43-63.6
Depreciation
Non-Cash Items1.633.99-1.684.745.3
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.052-0.221-8.42-3.93-0.836
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-29.1-48.8-44.1-40.4-17.6
Capital Expenditures-0.874-1.27-0.728-0.398-0.026
Purchase of Fixed Assets
Other Investing Cash Flow Items-14.2-76.43952.10
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-15.1-77.738.351.7-0.026
Financing Cash Flow Items-0.0040
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities50.1125-2.560.27616.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.88-1.89-8.411.6-1.48